PPAR Research

PPAR Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice

Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats

Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes

PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance

The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat

Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP

15-deoxy-Δ_12,14-prostaglandin J₂ Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF-κB and MAPK Signaling in HepG2 Cells

Correlation between PPAR Gene Polymorphisms and Primary Nephrotic Syndrome in Children

Effects of Three Different Fibrates on Intrahepatic Cholestasis Experimentally Induced in Rats

PPAR Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?

Does Pro¹²Ala Polymorphism Enhance the Physiological Role of PPAR2?

Physiological and Nutritional Roles of PPAR across Species

Role of Peroxisome Proliferator-Activated Receptor and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells

Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation

PPAR Research

Table of Contents

Table of Contents: 2013

PPAR Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice

Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats

Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes

PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance

The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat

Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP

15-deoxy-Δ_12,14-prostaglandin J₂ Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF-κB and MAPK Signaling in HepG2 Cells

Correlation between PPAR Gene Polymorphisms and Primary Nephrotic Syndrome in Children

Effects of Three Different Fibrates on Intrahepatic Cholestasis Experimentally Induced in Rats

PPAR Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?

Does Pro¹²Ala Polymorphism Enhance the Physiological Role of PPAR2?

Physiological and Nutritional Roles of PPAR across Species

Role of Peroxisome Proliferator-Activated Receptor and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells

Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation

PPAR Research

Table of Contents

Table of Contents: 2013

PPAR Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice

Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats

Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes

PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance

The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat

Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP

15-deoxy-Δ12,14-prostaglandin J2 Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF-κB and MAPK Signaling in HepG2 Cells

Correlation between PPAR Gene Polymorphisms and Primary Nephrotic Syndrome in Children

Effects of Three Different Fibrates on Intrahepatic Cholestasis Experimentally Induced in Rats

PPAR Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?

Does Pro12Ala Polymorphism Enhance the Physiological Role of PPAR2?

Physiological and Nutritional Roles of PPAR across Species

Role of Peroxisome Proliferator-Activated Receptor and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells

Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation

15-deoxy-Δ_12,14-prostaglandin J₂ Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF-κB and MAPK Signaling in HepG2 Cells

Does Pro¹²Ala Polymorphism Enhance the Physiological Role of PPAR2?